Huntington’s Disease - HCP
Huntington’s Disease - HCP supports healthcare professionals through independent medical education on diagnosis, treatment, and multidisciplinary care to strengthen Huntington’s disease management.
Funder: Teva
Due Dates: At least 60 days before the required decision date and activity start (complete request)
Funding Amounts: Not specified
Summary: Supports healthcare professional education on Huntington’s disease diagnosis, treatment options, and multidisciplinary management, including chorea care.
Key Information: Grants support educational providers, not individuals, including individual healthcare professionals.
Description
Teva supports independent medical education that strengthens healthcare professionals’ knowledge, competence, and confidence in diagnosing and managing Huntington’s disease. Education objectives include genetic factors, disease-state pathophysiology, the triad of symptoms affecting quality of life, disease burden, and the clinical profiles of treatment options.
A central priority is helping professionals recognize their own needs and patients’ unmet needs in managing Huntington’s disease-related chorea. Education should address early and continuous treatment, adherence, persistence, multidisciplinary management, appropriate treatment selection, long-term treatment, and barriers to care. Teva seeks innovative, high-quality initiatives offering evidence-based, clinically relevant, performance-based education.
